Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2012
05/18/2012WO2012027710A3 Compounds that modulate intracellular calcium
05/18/2012WO2012021014A3 Composition for preventing or treating diabetes or diabetes complications, containing composite composition of angelicae gigantis radix extract and wild garlic leaves extract as active ingredient
05/18/2012WO2012016229A3 Oxytocin treatment to improve memory and modify blood glucose
05/18/2012WO2011155705A9 Composition for inhibiting hyperlipidemia and obesity by inhibiting intestinal absorption of cholesterol
05/18/2012WO2011153429A9 Methods of treatment
05/18/2012WO2011139107A3 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and phamaceutical composition comprising the same
05/18/2012CA2817199A1 Crystalline solids of a metap-2 inhibitor and methods of making and using same
05/18/2012CA2817011A1 Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity
05/18/2012CA2815941A1 Ibat inhibitors for treatment of metabolic disorders and related conditions
05/18/2012CA2815698A1 A pharmaceutical combination comprising an ibat inhibitor and a bile acid binder
05/18/2012CA2815179A1 Lactam derivatives useful as orexin receptor antagonists
05/18/2012CA2813661A1 Pharmaceutical composition, methods for treating and uses thereof
05/17/2012US20120124703 Novel coprinus comatus and tremella mesenterica mushroom strains, products and extracts thereof and compositions comprising them
05/17/2012US20120122990 Oleoylethanolamide based functional mesophases
05/17/2012US20120122988 4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/17/2012US20120122984 Methods of Treating Lipomas and Liposarcomas
05/17/2012US20120122981 Biomarkers Related to Insulin Resistance and Methods using the Same
05/17/2012US20120122977 Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
05/17/2012US20120122959 Targeting MicroRNAs for Metabolic Disorders
05/17/2012US20120122954 Antisense Oligomers Targeting PCSK9
05/17/2012US20120122944 Tetrahydronaphthalene derivatives
05/17/2012US20120122941 Cycloalkylamine derivatives
05/17/2012US20120122940 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
05/17/2012US20120122934 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122924 Nampt inhibitors
05/17/2012US20120122922 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
05/17/2012US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator
05/17/2012US20120122912 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/17/2012US20120122907 Novel Pyrazole Derivatives and their use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
05/17/2012US20120122906 Novel sulfonamide derivative and pharmaceutical product containing same
05/17/2012US20120122905 Novel gpr 119 agonists
05/17/2012US20120122895 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122883 New salts
05/17/2012US20120122879 Compounds useful as protein kinase inhibitors
05/17/2012US20120122876 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
05/17/2012US20120122875 Salts of Methyl (R)-7-[3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyryl]-3-Trifluoromethyl-5,6,7,8-Tetrahydro-Imidazo[1,5-A]Pyrazine-1-Carboxylate
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122858 Lactam compounds and their use as pharmaceuticals
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122853 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
05/17/2012US20120122852 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122837 Inhibitors of fatty acid binding protein
05/17/2012US20120122835 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
05/17/2012US20120122806 Method of lowering glycemic index of foods
05/17/2012US20120122783 Glucagon antagonists
05/17/2012US20120122776 Dpp-iv inhibitors for treatment of diabetes in pediatric patients
05/17/2012US20120122775 Use of Ultrarapid Acting Insulin
05/17/2012US20120122774 Long-acting formulations of insulins
05/17/2012US20120122773 N-substituted-cyclic amino derivative
05/17/2012US20120122772 Agent for Suppressing Elevation of Blood GIP Concentration
05/17/2012US20120122771 STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/17/2012US20120122770 Cell Cycle Arrest and Apoptosis
05/17/2012US20120122765 Compounds and related methods for manipulating parp-1-dependent cell death
05/17/2012US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep
05/17/2012US20120121772 Purifying crude pufa oils
05/17/2012US20120121753 Compositions and methods for prevention and treatment of obesity and obesity related metabolic syndrome
05/17/2012US20120121741 Water soluble defructosylated pea extract, and use thereof as a prebiotic agent
05/17/2012US20120121735 Composition and Method for Reducing Food Intake
05/17/2012US20120121733 Deodorized edible oil or fat with low levels of bound mcpd and process of making using an inert gas
05/17/2012US20120121720 Modulation of Beta 2 Adrenergic Receptors by Inhibitors of EGLN3 or pVHL
05/17/2012US20120121711 Microsphere drug carrier, preparation method, composition and use thereof
05/17/2012US20120121707 Tolbutamide Particle And Preparing Method Thereof And Method Of Reducing A Blood Glucose
05/17/2012US20120121699 Lycopene and resveratrol dietary supplement
05/17/2012US20120121698 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
05/17/2012US20120121689 Small interfering rna delivery
05/17/2012US20120121654 Nanoparticle isoflavone compositions & methods of making and using the same
05/17/2012US20120121611 Method of treating autoimmune disease with mesenchymal stem cells
05/17/2012US20120121609 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
05/17/2012US20120121602 Novel proteins
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121578 Methods of using immunoglobulin aggregates
05/17/2012US20120121566 Solubilized CoQ-10
05/17/2012US20120121562 Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
05/17/2012US20120121560 Methods of expanding and redifferentiating islet beta cells
05/17/2012US20120121556 Methods of using regenerative cells to promote wound healing
05/17/2012US20120121554 Hmg-coa secondary metabolites and uses thereof
05/17/2012US20120121553 Selection and propagation of progenitor cells
05/17/2012US20120121539 Programming Of Cells for Tolerogenic Therapies
05/17/2012US20120121530 Vasoprotective and cardioprotective antidiabetic therapy
05/17/2012US20120121527 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARy TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/16/2012EP2453016A1 Methods for treating hypercholesterolemia
05/16/2012EP2453009A1 Methods of organ regeneration
05/16/2012EP2452937A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
05/16/2012EP2452690A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor
05/16/2012EP2452683A2 Methods for treating atherosclerosis
05/16/2012EP2451813A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
05/16/2012EP2451482A1 Combination therapy for the treatment of diabetes
05/16/2012EP2451472A1 Heat- and vibration-stable insulin preparations
05/16/2012EP2451471A1 Slow-acting insulin preparations
05/16/2012EP2451436A1 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes
05/16/2012EP2451298A1 Product for the storage of freeze-dried lactic acid bacteria mixed with a powder for an oral rehydration solution
1 ... 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 ... 1298